Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Metastatic colorectal cancer

Does vitamin D put the brakes on tumors?

    • Congress Reports
    • Gastroenterology and Hepatology
    • Oncology
    • RX
    • Studies
  • 2 minute read

Prospective analysis of a phase III trial of metastatic colorectal cancer shows that higher vitamin D levels provide better outcomes. Patients not only lived significantly longer, but also later became resistant to chemotherapy. Why is that? This question was explored at the 2015 Gastrointestinal Cancers Symposium in San Francisco.

The CALGB 80405 study served as the basis for the prospective analysis. In this, we investigated chemotherapy plus bevacizumab and/or cetuximab (before KRAS-WT adjustment) in patients with untreated metastatic colorectal cancer. Primarily, the analysis presented at the ASCO-GI Congress focused on the association between vitamin D level (25[OH]D) and overall survival. In addition, progression-free survival was also of interest. It is the largest study of its kind to date.
Plasma levels of vitamin D were collected at baseline by radioimmunoassay, and dietary and lifestyle habits by questionnaire. Median 25(OH)D was 17.2 ng/ml, corresponding to deficiency (range 2.2-72.7 ng/ml, n=1043). Nevertheless, only a vanishingly small proportion of patients reported taking vitamin D supplements.

33 percent risk reduction

Overall survival after chemotherapy and targeted therapy was significantly prolonged by approximately eight months in patients in the highest 25(OH)D quintile compared with data from the lowest quintile (32.6 vs. 24.5 months; HR 0.67, 95%CI 0.53-0.86, p-trend <0.002). The risk of mortality was thus a full 33% lower when patients had sufficiently high vitamin D levels. The same trend was found for progression-free survival (12.2 vs. 10.1 months; HR 0.80, 95% CI 0.64-1.01, p-trend = 0.02) – again, a 20% risk reduction. Pathologic and clinical factors that might play a role in prognosis were included in the calculation. Results were consistent across all subgroups (including KRAS mutation status). There was also no significant difference within the different treatment arms.

Open questions, future studies

Does vitamin D actually slow down tumor growth itself, and if so, how does this process take place? Or does vitamin D rather increase the activity of the treatment? These questions must remain open for the time being – however, data suggesting an antitumor effect are accumulating [1]. Despite the impressive results at first sight, the exact causal relationship between 25(OH)D and outcome factors in colorectal cancer remains obscure. Could there possibly be another factor at the beginning that affects both the vitamin D level and the tumor? In addition, this is an observational study with all the associated limitations. Therefore, studies are currently being planned to randomly test vitamin D supplementation in cancer, particularly in the indication of colorectal cancer. The effects are also to be tested in prevention.

A randomized, double-blind phase II trial with the two treatment arms standard chemotherapy plus bevacizumab and 400 IU/d vitamin D or the same regimen plus 8000 IU/d vitamin D for two weeks (initial dose) and 4000 IU/d vitamin D (maintenance dose) has already enrolled 80 subjects.

Source: Ng K, et al: Vitamin D status and survival of metastatic colorectal cancer patients: results from CALGB/SWOG 80405 (Alliance). J Clin Oncol 2015; 33(suppl 3; abstr 507).

Literature:

  1. Zgaga L, et al: Plasma Vitamin D Concentration Influences Survival Outcome After a Diagnosis of Colorectal Cancer. JCO 2014, July 7 [Epub ahead of print] doi: 10.1200/JCO.2013.54.5947.

InFo ONCOLOGY & HEMATOLOGY 2015; 3(3-4): 3.

Autoren
  • Andreas Grossmann
Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • Chemotherapy. Gastrointestinal Cancers Symposium
  • Colorectal Cancer
  • metastatic
  • San Francisco
  • Vitamin D level
Previous Article
  • Paroxysmal nocturnal hemoglobinuria

Rare, but well treatable – therefore remember it in practice!

  • General Internal Medicine
  • Hematology
  • News
  • RX
View Post
Next Article
  • Unclear skin lesion in three and a half year old boy

Inflammatory lump on the cheek – infectious?

  • Allergology and clinical immunology
  • Cases
  • Dermatology and venereology
  • Pediatrics
  • RX
View Post
You May Also Like
View Post
  • 5 min
  • Asthma in adults

When do pneumology specialists come into play?

    • RX
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.